|
|
|
| Webinar: Planning For Scale From The Start: Where Early Development Decisions Create Commercial Risk | Commercialization challenges often start long before commercial manufacturing. This Catalent webinar explores how emerging biopharma companies can connect development, manufacturing, quality, and supply planning earlier to prepare for future demand, reduce scale-up and technology transfer risk, and strengthen launch readiness. Learn how an accelerated, connected approach can build greater supply resilience as programs progress toward commercialization. Click here to learn more. |
|
|
|
Webinar | Abzena | Navigating complex bioconjugate development requires balancing clinical timelines with rigorous risk reduction. Discover how integrating advanced analytics and early developability assessments streamlines tech transfer and accelerates progress to market. |
|
|
|
Video | AGC Biologics | See how an integrated perfusion and intensified fed-batch approach enabled rapid development of a sensitive protein process and successful clinical trial material production. |
|
|
|
Video | Adare Pharma Solutions | With a proven history in drug delivery, Adare’s facilities in the US and Europe have developed and manufactured more than 65 products sold by customers worldwide. |
|
|
|
Video | West Pharmaceutical Services, Inc. | EU GMP Annex 1 is driving changes in how teams behave inside cleanrooms. Understand what contamination awareness really means in practice and how to build a culture where speaking up is standard. |
|
|
|
Video | Outsourced Pharma | This segment of the Outsourced Pharma Live event, “ADC Outsourcing: Plan Smart Now Or Suffer Later,” focuses on where the highest technical and regulatory risks sit in ADC manufacturing, especially when programs involve novel linker-payload chemistry, new mechanisms, or emerging drug-antibody conjugate approaches. |
|
|
|
Video | Future Fields | Achieve reliable, on-demand protein production with a manufacturing approach that minimizes scale-up risk from R&D through commercialization. |
|
|
|
Video | ElevateBio | Early process decisions can determine whether cell therapies scale efficiently. Explore how automation, robotics, facility design, and manufacturing expertise can reduce batch costs. |
|
|
|
|
| Webinar: USP <665>: Testing Of Plastic Components And Systems Used In Pharmaceutical Manufacturing | How do you build a defensible USP <665> extraction study? This Pace Life Sciences webinar explores the risk-based framework for evaluating plastic components and systems used in pharmaceutical and biopharmaceutical manufacturing. Learn how to determine scope, assign risk, select extraction conditions, interpret extractables and leachables, and develop complete study packages that support regulatory expectations and product safety. Click here to learn more. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
